Here’s the latest on CMS hospice enrollment moratorium based on recent reports:
CMS announced a six-month nationwide moratorium on new Medicare enrollments for hospices and home health agencies, aimed at curbing fraud and ensuring program integrity. The pause applies to new enrollments and certain ownership changes, but does not stop services for current patients or enrollments already in progress. This is intended to give CMS time to strengthen safeguards and enforcement.[1][2][4]
The policy was described as part of a broader anti-fraud push and aligns with ongoing efforts by the administration to scrutinize providers in high-risk areas. CMS officials emphasized protecting beneficiaries and taxpayer funds while investigations proceed.[2][1]
Coverage of the moratorium’s scope varies slightly by outlet, but common threads are: (1) nationwide across hospices and home health, (2) six-month duration, (3) grandfathering for existing providers, and (4) continuation of services for current patients. Some sources note related coordination with anti-fraud task forces and prior targeted moratoria in other sectors.[3][4][1][2]
Industry groups and legal analyses highlight practical implications: potential delays for prospective hospice providers or new branches, considerations for transactions involving ownership changes, and the need to document enrollment submissions for grandfathering eligibility. Several law firm briefings summarize the regulatory notices and procedural details.[4][8]
Public and trade coverage reflects a mix of caution and support for fraud controls, with some outlets noting concerns about access to care for vulnerable populations if the pause is interpreted too broadly, though CMS maintains current providers and patients are unaffected in terms of services.[5][9]
If you’d like, I can pull the specific CMS notices or provide a brief summary of the exact regulatory language and how it might affect a particular hospice or home health provider in your area. I can also assemble a quick one-page briefing with timelines, exemptions, and action items for providers.
Citations:
The Trump administration announced a six-month moratorium on Medicare enrollment for hospices and home health agencies in an effort to crack down on alleged rampant fraud across the service category.
news.bloomberglaw.comThe Trump administration will block new home healthcare and hospice providers from enrolling in Medicare for at least the next six months, a nationwide pause that takes aim at a sector where federal officials say fraud has spread too far. The moratorium will temporarily bar new providers in those categories from signing up for Medicare reimbursement, but it will not affect companies already registered. The move lands on May 13, 2026, and it puts the federal government’s fraud crackdown...
www.mogazmasr.comLearn if Medicare might stop new hospice providers from enrolling. See what this means for patients and what you can do. Get clear help from BenefitKarma.
benefitkarma.comCMS Enrollment MoratoriumCMS Freezes New Hospice and Home Health Enrollments Nationwide Industry leaders support fraud enforcement efforts but warn a broad moratorium could strain patient access and limit provider growth in vulnerable communities. A new six-month federal enrollment freeze aimed...
members.thinkhomecare.orgThe Centers for Medicare & Medicaid Services announced the six-month temporary suspension of enrollment of providers of hospice and home health agency services on Wednesday, in another administrative move to clamp down on fraud, waste and abuse.
www.washingtontimes.comRumors have circulated that the U.S. Centers for Medicare & Medicaid Services (CMS) is mulling a national moratorium on hospice provider enrollment in
hospicenews.comA group of state hospice associations have expressed mounting concerns that a rumored national moratorium prohibiting new provider enrollments could
hospicenews.comThe Centers for Medicare and Medicaid Services said it will pause the enrollment of new hospice and home health providers.
www.statnews.comThe Securities and Exchange Commission (“SEC”) remains active on both investigative and litigation fronts. Associate Director Lee emphasized that investor protection continues to be the agency’s central mandate, with enforcement efforts concentrated on misrepresentation and disclosure failures, market manipulation, insider trading and fraud using artificial intelligence.
www.beneschlaw.com